#SmallScreenScenes #MyFeetAreKillingMe @TLC #SoleSupport START THE NEW YEAR ON THE RIGHT FOOT WITH TLC’S ALL-NEW SERIES MY FEET ARE KILLING ME
Dr. Ebonie Vincent and Dr. Brad Schaeffer have never met a foot too funky to fix. TLC, the #1 cable network for women in primetime, proudly introduces these dynamic foot docs as the stars of its new nine-part medical transformation series MY FEET ARE KILLING ME, premiering Thursday, January 2 at 10PM ET/PT, after the return of DR. PIMPLE POPPER.
MY FEET ARE KILLING ME follows these expert podiatrists and surgeons as they bring their warm bedside manners to the task of restoring their patients’ confidence and getting them back on their feet. Throughout the series, viewers will immerse themselves with both doctors – one west coast and one east coast – as they juggle all sorts of eye-popping cases, from wart clusters and funky fungus, to toe amputations and foot reconstructions.
“It was clear, following the debut of DR. PIMPLE POPPER, that our audience was craving even more powerful and heartwarming stories of medical transformation,” said Howard Lee, President and General Manager of TLC. “With MY FEET ARE KILLING ME, we’re beyond excited for viewers to fall in love with Dr. Ebonie and Dr. Brad, who are tops in their field as well as exceedingly compassionate caregivers to their desperate patients. As with all series in TLC’s popular medical genre, we bring viewers along on emotional rollercoaster journeys through to their uplifting conclusions.”
Each hour-long episode follows three patients – who after years, if not decades of neglect – hopelessly turn to Dr. Ebonie and Dr. Brad to fix their unusual foot conditions so they may reclaim their lives and confidence. The gripping personal stories featured will include: a paranormal romance novelist who hopes to get her unwieldy and unsightly sixth toe amputated; an athlete with two dramatically different sized feet; a former professional dancer with a bunion so big she can hardly walk; a man suffering from Proteus syndrome, or the Elephant Man’s Disease which has left him with gigantic feet; a patient with a double big toe; a nudist with severe fungus; and an adorable toddler born with 12 toes. Tackling everything from grave ailments and cosmetic procedures to full foot reconstruction, these telegenic doctors use their expert surgical skills to fix embarrassing foot problems and change people’s lives.
Meet the Doctors:
Dr. Ebonie Vincent, DPM is a highly trained foot and ankle surgeon in Orange County, California. She has extensive experience in the latest treatments for foot and ankle conditions and specializes in minimally invasive surgical techniques, corrective and reconstructive foot and ankle surgery, diabetic limb salvage, pediatric foot conditions and sports medicine.
Dr. Vincent has co-authored several research articles, with published articles in the Journal of Orthopedic and Sports Physical Therapy (JOSPT). She has won research awards for poster and oral presentations through research presented at Des Moines University.
Dr. Brad Schaeffer, DPM worked hands-on with patients at Temple University School of Podiatric Medicine clinic in Philadelphia, PA from 2007 to 2011. During this time, he examined and assessed various conditions in a clinical setting. Dr. Schaeffer had the opportunity to rotate through several departments within TUSPM, including surgery, orthopedic department, wound care, podiatric medicine, diagnosis, physical therapy and radiology. He gained valuable knowledge in a clinical setting, successfully completed the NBOPME Board Part I and II and also became BLS-and ACLS Certified.
Prior to his time at Temple University, Dr. Schaeffer attended Palm Beach Atlantic University. He was a biology major, chemistry minor and business minor. Scholarships earned were the Christian Leadership Scholarship, Sailfish Award and a Provost Scholarship.
Join the conversation on social media by using the hashtag #MyFeetAreKillingMe and ‘Like’ TLC on Facebook.
MY FEET ARE KILLING ME is produced for TLC by Renegade 83 an Entertainment One Company.